Main publications

[1] Suslov KV. Does AID aid AIDS? Immunol Lett (2004);91:1-2

[2] Suslov KV. Towards an anti-(R5-X4 HIV-1 switching) vaccine based on prions. In: B.A. Veskler, Editor. New Research on Immunology. Nova Science Publishers. New York. pp.1-46. (2005)

[3] Suslov KV. AID-mediated somatic hypermutation for generation of viral envelope protein diversity in patient-specific therapeutic HIV vaccines based on induction of neutralizing antibodies. Immunol Lett (2010);128:86-87

[4] Suslov KV. Neutralization-enhancing RF antibodies for HIV vaccines. Front Immunol (2014) 5:634. doi: 10.3389/fimmu.2014.00634

[5] Suslov KV. Neutralization-enhancing RF antibodies. In: L.V.Berhardt, Editor. Advances in Medicine and Biology. Volume 87. Nova Science Publishers. New York. pp.81-106. (2015)

[6] Suslov KV. Orchestrating HIV neutralization by secondary immune response-mediated induction of RF antibodies.Curr Immunol Rev (2016); 12:118-124

[7] Suslov KV. Transient immunosuppression during short interruption of HAART: Another key to HIV cure in the “Berlin patient”? Med Hypotheses (2019); 123: 6-8

[8] Suslov KV, Berzina AG.Towards massive screening for HIV cure among HIV-infected injection drug users with long-term nonprogression to AIDS. International Scientific Forum “Science and Innovations - Modern Concepts” (Publishing company “Infinity” : Moscow, 5 October 2023, Russia). Part 2, pp.83-85 doi: 10.34660/INF.2023.88.75.366

[9] Suslov KV, Berzina AG. The phenomenon of long-term non-progression of HIV infection in injection drug users. Voprosy narkologii [Journal of addiction problems]. 2023;35(6):36–59. (In Russ.) pdf

[10] Suslov KV. Cytarabine-mediated transient immunosuppression regimen alone for HIV cure. International Scientific Forum “Science and Innovations - Modern Concepts” (Publishing company “Infinity” : Moscow, 1 August 2024, Russia), pp.144-148. doi: 10.34660/INF.2024.90.74.092

[11] Suslov KV. Transient immunosuppression with cytarabine between antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy: a successful regimen with a potential for HIV cure. International Scientific Forum “Scientific Dialog: Theory and Practice” (Publishing company “Infinity” : Moscow, 10 April 2025, Russia), pp.153-158. doi:10.34660/INF.2025.37.25.133